Literature DB >> 29377134

Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis.

Yoshinori Yasuda1, Shintaro Iwama1,2, Atsushi Kiyota1, Hisakazu Izumida1, Kohtaro Nakashima1, Naoko Iwata1, Yoshihiro Ito1, Yoshiaki Morishita1, Motomitsu Goto1, Hidetaka Suga1, Ryoichi Banno1, Atsushi Enomoto3, Masahide Takahashi3, Hiroshi Arima1, Yoshihisa Sugimura4.   

Abstract

Autoimmune hypophysitis (AH) is thought to be an autoimmune disease characterized by lymphocytic infiltration of the pituitary gland. Among AH pathologies, lymphocytic infundibulo-neurohypophysitis (LINH) involves infiltration of the neurohypophysis and/or the hypothalamic infundibulum, causing central diabetes insipidus resulting from insufficiency of arginine vasopressin secretion. The pathophysiological and pathogenetic mechanisms underlying LINH are largely unknown. Clinically, differentiating LINH from other pituitary diseases accompanied by mass lesions, including tumours, has often been difficult, because of similar clinical manifestations. We recently reported that rabphilin-3A is an autoantigen and that anti-rabphilin-3A antibodies constitute a possible diagnostic marker for LINH. However, the involvement of rabphilin-3A in the pathogenesis of LINH remains to be elucidated. This study was undertaken to explore the role of rabphilin-3A in lymphocytic neurohypophysitis and to investigate the mechanism. We found that immunization of mice with rabphilin-3A led to neurohypophysitis. Lymphocytic infiltration was observed in the neurohypophysis and supraoptic nucleus 1 month after the first immunization. Mice immunized with rabphilin-3A showed an increase in the volume of urine that was hypotonic as compared with control mice. Administration of a cocktail of monoclonal anti-rabphilin-3A antibodies did not induce neurohypophysitis. However, abatacept, which is a chimeric protein that suppresses T-cell activation, decreased the number of T cells specific for rabphilin-3A in peripheral blood mononuclear cells (PBMCs). It ameliorated lymphocytic infiltration of CD3+ T cells in the neurohypophysis of mice that had been immunized with rabphilin-3A. Additionally, there was a linear association between the number of T cells specific for rabphilin-3A in PBMCs and the number of CD3+ T cells infiltrating the neurohypophysis. In conclusion, we suggest that rabphilin-3A is a pathogenic antigen, and that T cells specific for rabphilin-3A are involved in the pathogenesis of neurohypophysitis in mice.
Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  autoimmunity; hypophysitis; neurohypophysitis; pituitary; rabphilin-3A; vasopressin

Mesh:

Substances:

Year:  2018        PMID: 29377134     DOI: 10.1002/path.5046

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center.

Authors:  Zenei Arihara; Kanako Sakurai; Satsuki Niitsuma; Ryota Sato; Shozo Yamada; Naoko Inoshita; Naoko Iwata; Haruki Fujisawa; Takashi Watanabe; Atsushi Suzuki; Kazuhiro Takahashi; Yoshihisa Sugimura
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.996

2.  Role of Rph3A in brain injury induced by experimental cerebral ischemia-reperfusion model in rats.

Authors:  Xianlong Zhu; Haiying Li; Wanchun You; Zhengquan Yu; Zongqi Wang; Haitao Shen; Xiang Li; Hao Yu; Zhong Wang; Gang Chen
Journal:  CNS Neurosci Ther       Date:  2022-04-25       Impact factor: 7.035

3.  Ketoacidosis, Hypertriglyceridemia and Acute Pancreatitis Induced by Soft Drink Polydipsia in a Patient with Occult Central Diabetes Insipidus.

Authors:  Yasutaka Tsujimoto; Tomoaki Nakamura; Jun Onishi; Naoto Ishimaru; Naoko Iwata; Haruki Fujisawa; Atsushi Suzuki; Yoshihisa Sugimura; Kazuo Chihara
Journal:  Intern Med       Date:  2021-08-06       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.